Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Asfotase alfa in Severely Affected Infants and Young Children with Hypophosphatasia
2009-009369-32Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Apr 2009
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of asfotase alfa in infantile hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Primary endpoint: Skeletal radiograph qualitative improvement. Started Apr 2009; status: completed.
02
Drugs
asfotase alfa
03
Conditions
infantile hypophosphatasia (HPP)
Beyond the preview
Go deeper on 2009-009369-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009369-32.